StonvexLoading…
StonvexStonvexStonvexCore line items from SHW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-20 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $6.66B | $5.67B | $23.57B | $17.98B | $11.62B |
Operating Income | Not available | $679.80M | $3.34B | $2.70B | $1.64B |
Net Income | Not available | $534.70M | $2.57B | $2.09B | $754.70M |
EPS (Diluted) | $3.53 | $2.15 | $10.26 | $8.34 | $5.00 |
Total Assets | Not available | $26.38B | $25.90B | $26.21B | $25.36B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $216.90M | $207.20M | $241.50M | $269.80M |
Free Cash Flow OCF − CapEx | Not available | $800.00K | $2.65B | $1.79B | $680.70M |
Shares Outstanding | Not available | 246.60M | 247.70M | 247.90M | 249.30M |